View drug registration information details.


ItemsRegistration information
ID335
No335
Brand NameOMEZOLE 20
IngredientsOMEPRAZOLE 20 MG
Dosage FormCAPSULE
Primary PackagingBLISTERPACK
StorageSTORE BELOW 25 C, PROTECT FROM MOISTURE
Shelf Life3 YEARS
Pack SizeBOX OF 4 X 7'S
Dispensing CategoryPrescription only
ATC Classification
Pharmaceutical ClassULCER TREATMENT
IndicationsTREATMENT OF REFLUX OESOPHAGITIS, DUODENAL ULCER, BENIGN GASTRIC ULCER, LONG TERM TREATMENT OF PATHOLOGIC GASTRIC HYPERSECRETION ASSOCIATED WITH ZOLLINGER-ELLISON SYNDROME
ContraindicationsHYPERSENSITIVITY
Side EffectsHAEMATOLOGIC ABNORMALITIS, ANEMIA, EOSINOPENIA, LEUKOCYTOSIS, NEUTROPENIA, PANCYTOPENIA, THROMBOCYTOPENIA, ABDOMINAL PAIN AND COLIC, ASTHENIA, CNS DISTURBANCE, DIZZINESS, HEADACHE, SOMNOLENCE, DIARRHEA, FLATULENCE
Unit Price
EDL Yes
DescriptionLIGHT CARAMEL OPAQUE AND FLESH OPAQUE CAPSULE WITH" OMEZOLE 20 "PRINTED ON ONE END AND "HOVID" PRINTED ON THE OTHER END OF THE CAPSULE, OFF - WHITE TO CREAMY PELLETS
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration NoMAL20000377AZ
Import Registration Date2015-07-04
ActivityCERTIFICATE RELEASED
Applied Date2023-03-16
FDD Registration No04 I 4915/20
FDD Registration Date2023-06-07
Expiry Date2026-06-06

Back to drug list